Arshad Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Arshad Khan has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
Rabia Usman
16 shared publicationsIbraheem Bushnak
6 shared publications- Moamen Salah Refat
Department of Chemistry, Main Campus, College of Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia
6 shared publications - Rabia Usman
School of Chemistry and Environmental Engineering , Sichuan University of Science & Engineering , Zigong , Sichuan 643000 , China
6 shared publications - Faiz-Ur Rahman
Inner Mongolia University
5 shared publications Ghaferah H. Al-Hazmi
Department of Chemistry, College of Science , Princess Nourah bint Abdulrahman University , P. O. Box 84428 , Riyadh 11671 , Saudi Arabia
4 shared publications
Latest Publications
- 22 September 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (19) , 7941-7952
DFT Insights on the Modulation of Different Bridging Groups for the Optical Properties of Charge-Transfer Cocrystal
- 22 September 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (19) , 7941-7952
DFT Insights on the Modulation of Different Bridging Groups for the Optical Properties of Charge-Transfer Cocrystal
- 13 August 2025
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 27 (38) , 6303-6313
Donor–acceptor architecture dictates emission properties: enhanced solid-state fluorescence in carbazole-based charge transfer cocrystals
The ability to precisely control fluorescence variations holds significant promise for applications in advanced display technologies, bioimaging, and optical sensors. However, achieving solid-state emission enhancement within a single system remains a challenge. In this study, we have developed two-component charge transfer (CT) aggregates composed of carbazole-derived donor (9-phenyl-9H-carbazole (PC) and 9-(p-tolyl)-9H-carbazole (TC)) and acceptor (2,3,5,6-tetrafluoroterephthalonitrile (TFN)) molecules exhibiting distinct enhancement in solid-state emission properties. Structural analysis reveals that the PC–TFN (4 : 1) cocrystal adopts a DAD⋯DAD configuration, while the TC–TFN (1 : 1) cocrystal forms a DADA arrangement, indicating strong CT interactions. The cocrystals exhibit a pronounced redshift in both UV absorption and fluorescence emission along with enhanced fluorescence quantum yields of 74.70% for PC–TFN and 54.07% for TC–TFN, and extended lifetime attributed to the CT interactions facilitated by π⋯π stacking between donor and acceptor molecules. Furthermore, quantum chemical calculations offer detailed insights into the modulation of luminescence properties, providing a more profound understanding of CT interactions and presenting a new strategy for designing materials with tunable fluorescence behavior.
- 13 August 2025
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 27 (38) , 6303-6313
Donor–acceptor architecture dictates emission properties: enhanced solid-state fluorescence in carbazole-based charge transfer cocrystals
The ability to precisely control fluorescence variations holds significant promise for applications in advanced display technologies, bioimaging, and optical sensors. However, achieving solid-state emission enhancement within a single system remains a challenge. In this study, we have developed two-component charge transfer (CT) aggregates composed of carbazole-derived donor (9-phenyl-9H-carbazole (PC) and 9-(p-tolyl)-9H-carbazole (TC)) and acceptor (2,3,5,6-tetrafluoroterephthalonitrile (TFN)) molecules exhibiting distinct enhancement in solid-state emission properties. Structural analysis reveals that the PC–TFN (4 : 1) cocrystal adopts a DAD⋯DAD configuration, while the TC–TFN (1 : 1) cocrystal forms a DADA arrangement, indicating strong CT interactions. The cocrystals exhibit a pronounced redshift in both UV absorption and fluorescence emission along with enhanced fluorescence quantum yields of 74.70% for PC–TFN and 54.07% for TC–TFN, and extended lifetime attributed to the CT interactions facilitated by π⋯π stacking between donor and acceptor molecules. Furthermore, quantum chemical calculations offer detailed insights into the modulation of luminescence properties, providing a more profound understanding of CT interactions and presenting a new strategy for designing materials with tunable fluorescence behavior.
- 29 July 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (15) , 5772-5781
Crystal Engineering Approach to Forming Cocrystals of Enaminones: Structural Insights into Enhanced Solid-State Luminescence
- 29 July 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (15) , 5772-5781
Crystal Engineering Approach to Forming Cocrystals of Enaminones: Structural Insights into Enhanced Solid-State Luminescence
- Open Access
Turning on the Heat by Cocrystal Engineering: The Rise of Organic Charge Transfer Photothermal Cocrystals as an Emerging Therapeutic Frontier in Biomedical Application
The field of molecular charge transfer cocrystals (CTCs) has advanced rapidly in recent years, with much work focused on their use in optoelectronic devices, photoacoustic imaging, photothermal therapy (PTT), optical waveguides, seawater desalination, and more. Organic photothermal CTCs are of particular interest because of their unique phototherapeutic effects in phototherapy and their remarkable imaging capabilities in fluorescence, magnetic resonance, and photoacoustic imaging, further enhancing their significance in medical applications. However, the use of photothermal CTCs in biomedicine has been limited, with few reported biological applications. Hence, there is a growing interest in CT‐derived functional photothermal cocrystals potential contenders for targeted and controlled biomedical applications such as bacteria inhibition, cancer eradication, and tissue regeneration. This review offers insight into the recent advancements in crafting and producing CT‐based materials with biomedical attributes. In addition, it outlines the current obstacles and future prospects in this burgeoning research domain, aiming to propel the continued advancement of CT‐based biomaterials toward enhanced biomedical utilities. Overall, cocrystal‐based near‐infrared (NIR) photothermal materials have the potential to revolutionize a wide range of medical and technological applications and are an active area of research in chemistry, materials science, and nanotechnology.
Open AccessTurning on the Heat by Cocrystal Engineering: The Rise of Organic Charge Transfer Photothermal Cocrystals as an Emerging Therapeutic Frontier in Biomedical Application
The field of molecular charge transfer cocrystals (CTCs) has advanced rapidly in recent years, with much work focused on their use in optoelectronic devices, photoacoustic imaging, photothermal therapy (PTT), optical waveguides, seawater desalination, and more. Organic photothermal CTCs are of particular interest because of their unique phototherapeutic effects in phototherapy and their remarkable imaging capabilities in fluorescence, magnetic resonance, and photoacoustic imaging, further enhancing their significance in medical applications. However, the use of photothermal CTCs in biomedicine has been limited, with few reported biological applications. Hence, there is a growing interest in CT‐derived functional photothermal cocrystals potential contenders for targeted and controlled biomedical applications such as bacteria inhibition, cancer eradication, and tissue regeneration. This review offers insight into the recent advancements in crafting and producing CT‐based materials with biomedical attributes. In addition, it outlines the current obstacles and future prospects in this burgeoning research domain, aiming to propel the continued advancement of CT‐based biomaterials toward enhanced biomedical utilities. Overall, cocrystal‐based near‐infrared (NIR) photothermal materials have the potential to revolutionize a wide range of medical and technological applications and are an active area of research in chemistry, materials science, and nanotechnology.
- 29 October 2024
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 24 (22) , 9511-9526
The DFT Revelation of Optical Properties for Solid-State Anthracene Chalcone Compounds Containing Halogen Groups Modulated by a Charge Transfer Cocrystal Strategy
- 29 October 2024
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 24 (22) , 9511-9526
The DFT Revelation of Optical Properties for Solid-State Anthracene Chalcone Compounds Containing Halogen Groups Modulated by a Charge Transfer Cocrystal Strategy
- 6 September 2024
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 24 (19) , 8085-8091
Acceptor-Induced Cooperative Mixed-Stacking Supramolecular Co-Assembly with Enhanced Emissive Characteristics
- 6 September 2024
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 24 (19) , 8085-8091
Acceptor-Induced Cooperative Mixed-Stacking Supramolecular Co-Assembly with Enhanced Emissive Characteristics
- Open Access
- 5 April 2024
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 239 (3) , 477-479
The crystal structure of 2,8-diethyl-1,3,7,9-tetramethyl-4λ4,5λ4-spiro[dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinine-5,2′-naphtho[1,8-de][1,3,2]dioxaborinine], C25H29BN2O2
C25H29BN2O2, monoclinic, P21/c (no. 14), a = 13.1591(3) Å, b = 13.9362(3) Å, c = 13.0463(3) Å, β = 112.066(3)°, V = 2217.29(10) Å3, Z = 4, R gt (F) = 0.0419, wR ref (F 2) = 0.1068, T = 150 K.
- 5 April 2024
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 239 (3) , 477-479
Open AccessThe crystal structure of 2,8-diethyl-1,3,7,9-tetramethyl-4λ4,5λ4-spiro[dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinine-5,2′-naphtho[1,8-de][1,3,2]dioxaborinine], C25H29BN2O2
C25H29BN2O2, monoclinic, P21/c (no. 14), a = 13.1591(3) Å, b = 13.9362(3) Å, c = 13.0463(3) Å, β = 112.066(3)°, V = 2217.29(10) Å3, Z = 4, R gt (F) = 0.0419, wR ref (F 2) = 0.1068, T = 150 K.
- Open Access
- 5 April 2024
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 239 (3) , 497-499
The crystal structure of unsymmetrical BOPHY C26H27BN4
C26H27BN4, monoclinic, C2/c (no. 15), a = 38.716(3) Å, b = 9.2723(6) Å, c = 27.3977(18) Å, β = 113.4790(10)°, V = 9021.1(11) Å3, Z = 16, Rgt(F) = 0.0520, wRref(F2) = 0.1440, T = 100 K.
- 5 April 2024
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 239 (3) , 497-499
Open AccessThe crystal structure of unsymmetrical BOPHY C26H27BN4
C26H27BN4, monoclinic, C2/c (no. 15), a = 38.716(3) Å, b = 9.2723(6) Å, c = 27.3977(18) Å, β = 113.4790(10)°, V = 9021.1(11) Å3, Z = 16, Rgt(F) = 0.0520, wRref(F2) = 0.1440, T = 100 K.